Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over?
Publication
, Journal Article
O'Connor, CM
Published in: JACC Heart Fail
June 2017
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
June 2017
Volume
5
Issue
6
Start / End Page
464 / 465
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Emergency Treatment
- Cardiotonic Agents
- Acute Disease
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M. (2017). Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over? JACC Heart Fail, 5(6), 464–465. https://doi.org/10.1016/j.jchf.2017.04.010
O’Connor, Christopher M. “Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over?” JACC Heart Fail 5, no. 6 (June 2017): 464–65. https://doi.org/10.1016/j.jchf.2017.04.010.
O’Connor CM. Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over? JACC Heart Fail. 2017 Jun;5(6):464–5.
O’Connor, Christopher M. “Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over?” JACC Heart Fail, vol. 5, no. 6, June 2017, pp. 464–65. Pubmed, doi:10.1016/j.jchf.2017.04.010.
O’Connor CM. Development of Acute Decompensated Heart Failure Therapies: Is the Journey Over? JACC Heart Fail. 2017 Jun;5(6):464–465.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
June 2017
Volume
5
Issue
6
Start / End Page
464 / 465
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Emergency Treatment
- Cardiotonic Agents
- Acute Disease
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology